IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+7.25%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$236M
AUM Growth
+$236M
(+6.1%)
Cap. Flow
-$178K
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
28.95%
Holding
152
New
10
Increased
24
Reduced
67
Closed
2
Top Buys
| 1 |
Scotiabank
BNS
|
$2.85M |
| 2 |
PX
Praxair Inc
PX
|
$1.46M |
| 3 |
CRISPR Therapeutics
CRSP
|
$1.13M |
| 4 |
iShares Russell 3000 ETF
IWV
|
$992K |
| 5 |
DuPont de Nemours
DD
|
$756K |
Top Sells
| 1 |
T Rowe Price
TROW
|
$1.3M |
| 2 |
Marriott International Class A Common Stock
MAR
|
$1.23M |
| 3 |
Schlumberger
SLB
|
$1.11M |
| 4 |
CELG
Celgene Corp
CELG
|
$906K |
| 5 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
$904K |
Sector Composition
| 1 | Healthcare | 17.28% |
| 2 | Technology | 14.83% |
| 3 | Energy | 14.12% |
| 4 | Financials | 12.42% |
| 5 | Industrials | 12.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$371B
| $2.86M | 1.21% |
31,079
-20
| -0.1% | -$1.84K |
|
|
27
Scotiabank
BNS
$77.2B
| $2.85M | 1.21% |
+44,221
| New | +$2.85M |
|
28
Merck
MRK
$212B
| $2.71M | 1.15% |
48,137
| – | – |
|
|
PX
29
DELISTED
Praxair Inc
PX
| $2.34M | 0.99% |
15,138
+9,438
| +166% | +$1.46M |
|
30
Church & Dwight Co
CHD
$22.7B
| $2.33M | 0.99% |
46,516
-1,309
| -3% | -$65.7K |
|
31
Labcorp
LH
$23B
| $2.33M | 0.99% |
14,592
+260
| +2% | +$41.5K |
|
32
Oracle
ORCL
$629B
| $2.32M | 0.98% |
49,072
+730
| +2% | +$34.5K |
|
33
Colgate-Palmolive
CL
$68B
| $2.28M | 0.97% |
30,220
-574
| -2% | -$43.3K |
|
34
Duke Energy
DUK
$95.4B
| $2.25M | 0.95% |
26,804
-214
| -0.8% | -$18K |
|
35
Marsh & McLennan
MMC
$102B
| $2.24M | 0.95% |
27,535
+1,835
| +7% | +$149K |
|
36
PepsiCo
PEP
$209B
| $2.24M | 0.95% |
18,652
| – | – |
|
37
Truist Financial
TFC
$59.3B
| $2.18M | 0.92% |
43,760
-2,125
| -5% | -$106K |
|
38
McDonald's
MCD
$224B
| $1.97M | 0.83% |
11,433
-32
| -0.3% | -$5.51K |
|
39
Biogen
BIIB
$20.2B
| $1.89M | 0.8% |
5,936
+346
| +6% | +$110K |
|
40
Novartis
NVS
$245B
| $1.88M | 0.8% |
22,388
| – | – |
|
|
CELG
41
DELISTED
Celgene Corp
CELG
| $1.86M | 0.79% |
17,788
-8,685
| -33% | -$906K |
|
42
AT&T
T
$209B
| $1.82M | 0.77% |
46,770
+141
| +0.3% | +$5.48K |
|
43
GE Aerospace
GE
$288B
| $1.79M | 0.76% |
102,640
-31,436
| -23% | -$549K |
|
44
Bristol-Myers Squibb
BMY
$96.1B
| $1.75M | 0.74% |
28,617
| – | – |
|
45
Royal Caribbean
RCL
$95.7B
| $1.66M | 0.7% |
13,894
+125
| +0.9% | +$14.9K |
|
46
Coca-Cola
KO
$295B
| $1.62M | 0.69% |
35,325
-60
| -0.2% | -$2.75K |
|
47
Thermo Fisher Scientific
TMO
$182B
| $1.52M | 0.64% |
7,990
+30
| +0.4% | +$5.7K |
|
48
Verizon
VZ
$186B
| $1.46M | 0.62% |
27,610
-75
| -0.3% | -$3.97K |
|
49
Akamai
AKAM
$11.1B
| $1.43M | 0.61% |
22,024
+155
| +0.7% | +$10.1K |
|
50
TotalEnergies
TTE
$136B
| $1.39M | 0.59% |
25,174
| – | – |
|